medigraphic.com
ISSN 1405-8790 (Print)

2021, Number 1-4

<< Back Next >>

Rev Mex Med Fis Rehab 2021; 33 (1-4)

Cardiovascular autonomic neuropathy in recovered COVID-19 patients: case report

Varela-Tapia CL, Ramírez-Morales MF, Martínez-Barro D, Torres-Carranza EA, Hernández-Amaro H, Jiménez-Cruz R

Language: Spanish
References: 22
Page: 30-35
PDF size: 203.91 Kb.


ABSTRACT

Objective: To analyze cardiac autonomic cardiovascular alterations in patients recovered from COVID-19. Material and methods: Four autonomic tests were carried out using the Viking IV Master Software V5.1 equipment. Results: Cardiovascular autonomic neuropathy was diagnosed in recovered COVID-19 patients. Remaining symptoms: weakness in four limbs and dyspnea on small efforts. Conclusions: Our two cases highlight that the virus is capable of not only damaging the lungs, but also the nervous system. Analysis of cardiac abnormalities in patients recovering from COVID-19 suggests that the disease may have been a trigger for cardiac autonomic neuropathy.


REFERENCES

  1. Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 2020; 87 (4): 281-286.

  2. Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020; 14 (3): 247-250.

  3. Verstrepen K, Baisier L, De Cauwer H. Neurological manifestations of COVID-19, SARS and MERS. Acta Neurol Belg. 2020; 120: 1051-1060. Available in: https://doi.org/10.1007/s13760-020-01412-4

  4. Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg. 2020; 194: 105921.

  5. Lantos JE, Strauss SB, Lin E. COVID-19-associated Miller Fisher syndrome: MRI findings. AJNR Am J Neuroradiol. 2020; 41 (7): 1184-1186.

  6. Homma Y, Watanabe M, Inoue K, Moritaka T. Coronavirus disease-19 pneumonia with facial nerve palsy and olfactory disturbance. Intern Med. 2020; 59 (14): 1773-1775.

  7. Lo YL, Leong HN, Hsu LY, Tan TT, Kurup A, Fook-Chong S et al. Autonomic dysfunction in recovered severe acute respiratory syndrome patients. Can J Neurol Sci. 2005; 32 (2): 264.

  8. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985; 8 (5): 491-498.

  9. Agashe S, Petak S. Cardiac autonomic neuropathy in diabetes mellitus. Methodist Debakey Cardiovasc J. 2018; 14 (4): 251-256.

  10. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77 (6): 683-690.

  11. Fiani B, Covarrubias C, Desai A, Sekhon M, Jarrah R. A contemporary review of neurological sequelae of COVID-19. Front Neurol. 2020; 11: 640.

  12. Metelka R. Heart rate variability - Current diagnosis of the cardiac autonomic neuropathy. A review. Biomed Pap. 2014; 158 (3): 327-338.

  13. Aggarwal G, Henry BM, Aggarwal S, Bangalore S. Cardiovascular safety of potential drugs for the treatment of coronavirus disease 2019. Am J Cardiol. 2020; 128: 147-150.

  14. Convertino VA, Doerr DF, Eckberg DL et al. Head-down bed rest impairs vagal baroreflex responses and provokes orthostatic hypotension. J Appl Physiol. 1990; 68: 1458-1464.

  15. Greenleaf JE. Physiological responses to prolonged bed rest and fluid immersion in humans. J Appl Physiol Respir Environ Exerc Physiol. 1984; 57 (3): 619-633.

  16. Ghosh R, Roy D, Sengupta S, Benito-León J. Autonomic dysfunction heralding acute motor axonal neuropathy in COVID-19. J Neurovirol. 2020; 26 (6): 964-966.

  17. Vinik AI, Erbas T, Casellini CM. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. J Diabetes Investig. 2013; 4 (1): 4-18.

  18. Inoue H, Zipes DP. Time course of denervation of efferent sympathetic and vagal nerves after occlusion of the coronary artery in the canine heart. Circ Res. 1988; 62 (6): 1111-1120.

  19. Parthenakis FI, Prassopoulos VK, Koukouraki SI, Zacharis EA, Diakakis GF, Karkavitsas NK et al. Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy: relationship to regional wall motion and myocardial perfusion abnormalities. J Nucl Cardiol. 2002; 9 (1): 15-22.

  20. Stevens MJ, Raffel DM, Allman KC, Schwaiger M, Wieland DM. Regression and progression of cardiac sympathetic dysinnervation complicating diabetes: an assessment by C-11 hydroxyephedrine and positron emission tomography. Metabolism. 1999; 48 (1): 92-101.

  21. Fisher VL, Tahrani AA. Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives. Diabetes Metab Syndr Obes. 2017; 10: 419-434.

  22. Farrell TG, Bashir Y, Cripps T et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol. 1991; 18: 687-697.




2020     |     www.medigraphic.com